// App-Quantinova.ai

1917 : Suppression of miR-101a contributes to leukemogenesis by regulating epigenetic and pro-survival pathways in MLL AML stem cells

Researchers

Presenter

  • Estrella Gonzales-Aloy

Principal Investigators

  • Murray D. Norris

  • Jenny Y. Wang

Medical Centers

  • Children's Cancer Institute, University of New South Wales, Sydney, Australia.

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A